Arturo Araya

Arturo Araya is a seasoned professional with 20 years of experience in the pharmaceutical industry, currently serving as the Chief Commercial Officer for Brainstorm Cell Therapeutics.

With a background that includes leading global teams through product launches, growth phases, and loss of exclusivity, Mr. Araya has worked across diverse therapeutic areas such as Neuroscience, Cardiovascular, Oncology, and Cell & Gene Therapies.

He holds an MA and a BS from the University of Connecticut, as well as an MBA from the University of Michigan's Stephen M. Ross School of Business.

Prior to his current role, Mr. Araya held various executive positions at Novartis, including Chief Commercial Officer for the Cell & Gene Therapies Unit, Vice President for Global Commercial Strategy in CAR-T Therapies, and Global Brand Leader for Zometa & Femara.

His international experience spans countries such as the Nordic Cluster, the Czech Republic, Slovakia, and regions in Europe.

In addition to his pharmaceutical expertise, Mr. Araya is also the business owner of a commercial property management company.

His previous roles at Novartis, Bristol-Myers Squibb, Dow Chemical, and The Dow Chemical Company have equipped him with a well-rounded skill set in marketing, business development, and leadership.

Mr. Araya's academic achievements and extensive professional background position him as a highly accomplished and versatile leader in the pharmaceutical and commercial industries.